Melanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Michael Hahne(Centre National de la Recherche Scientifique), J Tschopp(University of Lausanne), D Liénard(Hôpital Orthopédique de la Suisse Romande), Lars E. French(University of Miami), Pascal Schneider(Forschungszentrum Jülich), Max H. Schreier(Ludwig Cancer Research), Donata Rimoldi(Ludwig Cancer Research), A. Fontana(Astronomical Observatory of Rome), Pedro Romero(TiGenix (Spain)), Michael Schröter(University of Lausanne), J C Cerottini(Ludwig Cancer Research), Thierry Bornand(University of Lausanne)
Cited by 1,265
Related Papers
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
TLR3 Deficiency in Patients with Herpes Simplex Encephalitis
|Science|2007|1.1k
THE LESSER ROLE OF STARBURSTS IN STAR FORMATION AT <i>z</i> = 2
|The Astrophysical Journal Letters|2011|862
APRIL, a New Ligand of the Tumor Necrosis Factor Family, Stimulates Tumor Cell Growth
|The Journal of Experimental Medicine|1998|506
Metabolic and epigenetic regulation of T-cell exhaustion
|Nature Metabolism|2020|443